- Home
- GLMD vs PRTG Comparison
GLMD vs PRTG Comparison
Compare GLMD & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- PRTG
- Stock Information
- Founded
- GLMD 2000
- PRTG 1973
- Country
- GLMD Israel
- PRTG British Virgin Islands
- Employees
- GLMD N/A
- PRTG N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- PRTG Oil & Gas Production
- Sector
- GLMD Health Care
- PRTG Energy
- Exchange
- GLMD Nasdaq
- PRTG Nasdaq
- Market Cap
- GLMD 4.6M
- PRTG 4.7M
- IPO Year
- GLMD 2014
- PRTG N/A
- Fundamental
- Price
- GLMD $3.04
- PRTG $5.19
- Analyst Decision
- GLMD
- PRTG Hold
- Analyst Count
- GLMD 0
- PRTG 1
- Target Price
- GLMD N/A
- PRTG N/A
- AVG Volume (30 Days)
- GLMD 45.4K
- PRTG 1.9M
- Earning Date
- GLMD 01-03-2025
- PRTG 11-26-2024
- Dividend Yield
- GLMD N/A
- PRTG N/A
- EPS Growth
- GLMD N/A
- PRTG N/A
- EPS
- GLMD N/A
- PRTG N/A
- Revenue
- GLMD N/A
- PRTG N/A
- Revenue This Year
- GLMD N/A
- PRTG N/A
- Revenue Next Year
- GLMD N/A
- PRTG N/A
- P/E Ratio
- GLMD N/A
- PRTG N/A
- Revenue Growth
- GLMD N/A
- PRTG N/A
- 52 Week Low
- GLMD $2.56
- PRTG $2.10
- 52 Week High
- GLMD $23.80
- PRTG $40.80
- Technical
- Relative Strength Index (RSI)
- GLMD 49.68
- PRTG 51.05
- Support Level
- GLMD $2.81
- PRTG $5.35
- Resistance Level
- GLMD $3.35
- PRTG $12.89
- Average True Range (ATR)
- GLMD 0.26
- PRTG 1.22
- MACD
- GLMD 0.05
- PRTG 0.17
- Stochastic Oscillator
- GLMD 57.83
- PRTG 22.54
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.